Letter From the Commissioner’s Office at the US FDA John A. Vernon EditorialNotes 25 November 2012 Pages: 1 - 2
Rates and Probabilities in Economic Modelling Rachael L. FleurenceChristopher S. Hollenbeak Practical Application 25 November 2012 Pages: 3 - 6
Reducing the Societal Burden of Depression Julie M. DonohueHarold Alan Pincus Review Article 25 November 2012 Pages: 7 - 24
Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants Judith E. BosmansOscar H. BrookMaurits W. van Tulder Original Research Article 25 November 2012 Pages: 25 - 37
A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK Dominic P. TildenSegundo MarizAlexander Diamantopoulos Original Research Article 25 November 2012 Pages: 39 - 54
Cost Effectiveness of Palivizumab for Respiratory Syncytial Virus Prophylaxis in High-Risk Children Mark J. C. NuijtenWolfgang WittenbergMaximilian Lebmeier Original Research Article 25 November 2012 Pages: 55 - 71
Time Preferences for Health in Northern Tanzania Bjarne RobberstadJohn Cairns Original Research Article 25 November 2012 Pages: 73 - 88